Description
Creative Biolabs provides a bioluminescent reporter assay for quantifying biological activity on pathway activation by therapeutic antibody drugs in an ADCC mechanism of action assay. This assay kit contains all the components and reagents necessary to perform the ADCC reporter assay on the test antibody, including human PBMC, Ramos target cell, medium, FBS and a luciferase detection system. This bioassay with low variability and high accuracy is suitable for applications across antibody drug research, development and functional research.
Features
Simple and highly sensitive;
Convenience and minimizes variability;
Easily applicable to high-throughput workflows.
Applications
Primary Cell-Based ADCC Assays
Molecular Mechanism of Action
When the HiBiT-expressing target cells are incubated with an antibody and PBMCs, the target cells are lysed and release HiBiT proteins. The HiBiT binding to the complementary polypeptide LgBiT can reconstruct a functional luciferase and generate a luminescent signal. Luciferase activity is quantified with luminescence readout.
Detection Method
Bioluminescent detection
Research Areas
Drug discovery; Function assay

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.